AIMC Topic: Non-alcoholic Fatty Liver Disease

Clear Filters Showing 131 to 139 of 139 articles

Accurate and generalizable quantitative scoring of liver steatosis from ultrasound images scalable deep learning.

World journal of gastroenterology Jun 14, 2022
BACKGROUND: Hepatic steatosis is a major cause of chronic liver disease. Two-dimensional (2D) ultrasound is the most widely used non-invasive tool for screening and monitoring, but associated diagnoses are highly subjective.
Humans Retrospective Studies Fatty Liver Liver Non-alcoholic Fatty Liver Disease Elasticity Imaging Techniques Reproducibility of Results Deep Learning ROC Curve
View on PubMed DOI

Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver.

Journal of the Chinese Medical Association : JCMA Sep 1, 2021
BACKGROUND: The prevalence of nonalcoholic fatty liver disease is increasing over time worldwide, with similar trends to those of diabetes and obesity. A liver biopsy, the gold standard of diagnosis, is not favored due to its invasiveness. Meanwhile,...
Non-alcoholic Fatty Liver Disease Abdomen United States Patient Acuity Deep Learning Ultrasonography Humans Retrospective Studies
View on PubMed DOI

Quantification of Liver Steatosis: Is CT Equivalent to PDFF?

AJR. American journal of roentgenology Apr 1, 2021
Deep Learning Humans Non-alcoholic Fatty Liver Disease Tomography, X-Ray Computed Reference Standards Adult
View on PubMed DOI

Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis.

Journal of gastroenterology and hepatology Mar 1, 2021
Artificial intelligence (AI) has become increasingly widespread in our daily lives, including healthcare applications. AI has brought many new insights into better ways we care for our patients with chronic liver disease, including non-alcoholic fatt...
Humans Neural Networks, Computer Logistic Models Liver Cirrhosis Liver Decision Trees Artificial Intelligence Forecasting Electronic Health Records Diagnostic Imaging Biopsy Non-alcoholic Fatty Liver Disease
View on PubMed DOI

Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection.

Metabolic syndrome and related disorders Nov 1, 2019
We investigated the prevalence and the most relevant features of nonalcoholic steatohepatitis (NASH), a stage of nonalcoholic fatty liver disease, (NAFLD) in which the inflammation of hepatocytes can lead to increased cardiovascular risk, liver fibr...
Non-alcoholic Fatty Liver Disease Hypertension Metabolic Syndrome Decision Making Male Middle Aged Disease Progression Diabetes Mellitus, Type 2 Liver Cirrhosis Prevalence Severity of Illness Index Adult Sensitivity and Specificity Cross-Sectional Studies Retrospective Studies Female Aged Algorithms Prognosis Humans Machine Learning
View on PubMed DOI

Interaction Effects of Gene Polymorphisms and Obesity on Nonalcoholic Fatty Liver Disease.

Biomedical and environmental sciences : BES Oct 1, 2019
Female Aged Humans Non-alcoholic Fatty Liver Disease Polymorphism, Genetic Multifactor Dimensionality Reduction China Aged, 80 and over Models, Theoretical Male Obesity Middle Aged
View on PubMed DOI

Quantification of hepatic steatosis in histologic images by deep learning method.

Journal of X-ray science and technology Jan 1, 2019
OBJECTIVE: To develop and test a novel method for automatic quantification of hepatic steatosis in histologic images based on the deep learning scheme designed to predict the fat ratio directly, which aims to improve accuracy in diagnosis of non-alco...
Liver Diet, High-Fat Rabbits Non-alcoholic Fatty Liver Disease Animals Male Deep Learning Neural Networks, Computer Tomography, X-Ray Computed Female
View on PubMed DOI

[Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology Dec 20, 2017
To investigate the effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides (FOS) on non-alcoholic fatty liver disease (NAFLD) in mice and its possible mechanism. A total of 50 male C57 mice were randomly and equally divided in...
Diet, High-Fat Rats Animals Probiotics Oligosaccharides Rats, Sprague-Dawley Male Non-alcoholic Fatty Liver Disease Lacticaseibacillus paracasei Mice Liver
View on PubMed DOI

Visfatin and TGF-Β1 in primary biliary cirrhosis and two other common liver diseases.

Folia medica Cracoviensia Jan 1, 2015
UNLABELLED: The aim of this study is to investigate plasma concentration of visfatin and transforming growth factor Β1 (TGF-Β1) in three groups of patients: primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (NAFLD) and toxic cirrhosi...
Adult Male Middle Aged Biomarkers Female Nicotinamide Phosphoribosyltransferase Humans Risk Factors Transforming Growth Factor beta1 Cytokines Non-alcoholic Fatty Liver Disease Case-Control Studies Liver Cirrhosis, Alcoholic Enzyme-Linked Immunosorbent Assay Liver Cirrhosis
View on PubMed
Popular Topics
Recent Journals